Luigi Meneghini

Luigi Meneghini

Sanofi US - New Jersey / United States
Others
AD Scientific Index ID: 4386189
-
person_outline Luigi Meneghini's MOST POPULAR ARTICLES
1-) Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy studyM Peyrot, AH Barnett, LF Meneghini, PM Schumm‐DraegerDiabetic Medicine 29 (5), 682-689, 20126362012
2-) Lower within‐subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetesT Haak, A Tiengo, E Draeger, M Suntum, W WaldhäuslDiabetes, Obesity and Metabolism 7 (1), 56-64, 20054162005
3-) Albumin‐bound basal insulin analogues (insulin detemir and NN344): comparable time‐action profiles but less variability than insulin glargine in type 2 diabetesO Klein, J Lynge, L Endahl, B Damholt, L Nosek, T HeiseDiabetes, Obesity and Metabolism 9 (3), 290-299, 20073472007
4-) The efficacy and safety of insulin degludec given in variable once-daily dosing intervals compared with insulin glargine and insulin degludec dosed at the same time daily: a 26 …L Meneghini, SL Atkin, SCL Gough, I Raz, L Blonde, M Shestakova, ...Diabetes care 36 (4), 858-864, 20133402013
5-) Patient‐directed titration for achieving glycaemic goals using a once‐daily basal insulin analogue: an assessment of two different fasting plasma glucose targets‐the TITRATETM …L Blonde, M Merilainen, V Karwe, P Raskin, TITRATE™ Study GroupDiabetes, Obesity and Metabolism 11 (6), 623-631, 20092722009